A review of data gathered from 12 clinical trials, involving nearly 23,000 individuals diagnosed with cardiovascular issues, revealed a significant reduction in acute cardiac events.
Over a six-month span, participants were administered low amounts of colchicine, specifically 0.5 mg either once or twice daily.
More precisely, for every thousand subjects receiving the medication, there were 8 fewer instances of myocardial infarction and 9 fewer instances of stroke when compared to the placebo group.
The researchers highlight that persistent inflammation plays a major role in the progression of atherosclerosis, which is the primary driver behind heart attacks and strokes.
About the Author
